BRIEF-KOLEN announces patent granted

* Says it receives a patent on Aug. 12, for photographic

lens optical system

Read more

BRIEF-Zhejiang Conba Pharmaceutical unit gets nod for clinic trial

Aug 12 (Reuters) - Zhejiang Conba Pharmaceutical Co., Ltd.

:

Read more

Gilead to get attorney fees in hepatitis C patent fight with Merck

Aug 11 (Reuters) - Gilead Sciences Inc is entitled

to receive the attorney fees it incurred related to hepatitis C

patent litigation with drugmaker Merck & Co Inc, a U.S.

district judge has ruled.

Read more

BRIEF-Northwest healthcare properties REIT Q2 adjusted FFO per share C$0.22

* Qtrly revenues from investment properties of $64.2

million, increase of 43% over same period last year

Read more

BRIEF-Cempra appoints David Zaccardelli to board of directors

* Cempra appoints Dr. David Zaccardelli to board of

directors

Source text for Eikon:

Further company coverage:

Read more

AstraZeneca wins UK cost approval for longer use of heart drug

LONDON, Aug 12 (Reuters) - Long term use of AstraZeneca's

blood thinner Brilinta has been recommended as a

cost-effective option for treating patients after a heart

attack, Britain's healthcare cost watchdog NICE said on Friday.

Read more

UPDATE 1-MSCI adds, removes one company from All World Index, moves Lending Club to small cap

Aug 11 (Reuters) - U.S. index provider MSCI announced on

Thursday that the only change to its All Country World Index

will be to add Liberty Broadband C to and remove Ionis

Pharmaceuticals Inc, both U.S. stocks.

Read more